Skip to content

Cumberland Pharmaceuticals CPIX Secured lines of credit

Secured lines of credit at other companies

Dominion Energy logo
Dominion EnergyD
$0
Jefferies Financial Group logo
Jefferies Financial GroupJEF
$424.02M+1,807%
Jefferies Financial Group logo
Jefferies Financial GroupJEF
$2.29B+0.3%
APO
Apogee EnterprisesAPOG
$25M-24.2%
MillerKnoll logo
MillerKnollMLKN
$243.8M-8.0%
American Electric Power logo
American Electric PowerAEP
$900M

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LongTermLineOfCredit.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's secured lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's secured lines of credit?
Cumberland Pharmaceuticals (CPIX) reported secured lines of credit of $5.24M in Q1 2026.
How has Cumberland Pharmaceuticals's secured lines of credit changed year-over-year?
Cumberland Pharmaceuticals's secured lines of credit decreased by 0.0% year-over-year, from $5.24M to $5.24M.
What is the long-term trend for Cumberland Pharmaceuticals's secured lines of credit?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's secured lines of credit has grown at a -19.0% compound annual growth rate (CAGR), from $15M to $5.24M.